Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, ...

A recent Kaiser Family Foundation Health Tracking Poll found one-in-eight U.S. adults, or 12 percent of the U.S. population, have said they took a GLP-1 agonist at one point. Sixty-two percent of ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

College students eat more in groups and formal dining locations, which may provide an explanation for weight gain known as ...

Novo Nordisk reports Wegovy users lost 21% body weight and saw improved heart health markers, as EMA and FDA reviews near for ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, MFOMA. Stopping Weight Loss Medication: What Happens and How to ...

This year’s import expo features gastric balloons, watches claimed to stimulate fullness, and interactive booths that measure body composition.

Despite cost, many employers said they saw the coverage as a potential way to improve health outcomes for workers.

Oral semaglutide improved glycemic parameters and cardiovascular risk factors for adults with overweight or obesity, with ...

Your body maintains a biological “set point” for weight, beyond calories, through powerful hormonal and neural feedback loops ...

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...

Protein is popping up in everything from popcorn to coffee. Here’s why it’s trending and what you need to know.